Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Is Imfinzi The Culprit As Advaxis Combo Trial Goes On Hold After Death?
Mar 13 2018
•
By
Kevin Grogan
At least for the moment: The FDA has stopped Advaxis' trial after patient death • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Clinical Trials
More from R&D